牛牛AI助理已提取核心讯息药明合联生物技术宣布,将于2025年8月18日(星期一)召开董事会会议,主要议程为审议及批准集团截至2025年6月30日止六个月的中期业绩及其发布事宜。公司执行董事兼首席执行官李锦才博士将出席会议,董事会现有成员包括三名执行董事、三名非执行董事及三名独立非执行董事。药明合联生物技术宣布,将于2025年8月18日(星期一)召开董事会会议,主要议程为审议及批准集团截至2025...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.